James N. Wilson

Biography

Jim has served as Chairman of the Board for Corcept Therapeutics since 1999, a company focused on the discovery and development of drugs that regulate the effects of cortisol From 2002 to 2009, he served as the lead independent director of Amylin Pharmaceuticals, Inc., a publicly-traded biopharmaceutical company, and from 1996 to 2001 Jim was Chairman of the Board of Amira Medical, Inc., which was acquired by Hoffmann-La Roche A.G. From 1991 to 1994, he was Chief Operating Officer of Syntex Corporation, which was acquired by Roche Holding, Ltd. From 1989 to 1990, Jim was Chairman and Chief Executive Officer of Neurex Corporation, which was acquired by Elan Corporation plc, and from 1982 to 1988, Jim was Chief Executive Officer of LifeScan, Inc., which was acquired by Johnson & Johnson Company. Jim received his BA and MBA from the University of Arizona.

Research Interest

Genomics, Molecular biology, Business management